None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Men over 50 -Complaints of lower urinary tract symptoms, which refer to storage symptoms(urine frequency more than 8 times a day, nocturia, urgency) and voiding symptoms(hesitancy, intermittency, straining) -Ultrasonically sized prostate larger than 25g or diagnosed with benign prostatic hyperplasia
Exclusion criteria
Exclusion criteria: -Prostate cancer, prostatitis syndrome, bladder tumor, urinary stone, urethral stricture, bladder neck structure, lower urinary tract (bladder, urethral) inflammation, urinary tuberculosis -Diagnosed as a neurogenic bladder due to cerebrovascular disease, brain tumor, cerebral palsy, Parkinson's disease, multiple system atrophy, multiple sclerosis, spinal cord injury, autonomic nerve hyperreflexia, spinal cord dysplasia, pelvic surgery, herpes virus infection or diabetes - Prostate specific antigen level = 10 ng / mL - A man who refuse to accept participation in research - A person who is considered to be ineligible for participation in clinical trials due to the test result or other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| reliability of instrument of pattern identification for Benign Prostatic Hyperplasia;validity of instrument of pattern identification for Benign Prostatic Hyperplasia; analyze correlation between IPSS, uroflowmetry, the remaining urine amounts, sasang constitution and instrument of pattern identification for Benign Prostatic Hyperplasia | — |
Secondary
| Measure | Time frame |
|---|---|
| analyze correlation between tongue diagnosis, pulse diagnosis and instrument of pattern identification for Benign Prostatic Hyperplasia | — |
Countries
Korea, Republic of
Contacts
Dunsan Korean Medicine Hospital of Daejeon University